Kunio Morozumi
Overview
Explore the profile of Kunio Morozumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, et al.
Kidney Int Rep
. 2022 Oct;
7(10):2283-2288.
PMID: 36217532
No abstract available.
12.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, et al.
Sci Rep
. 2022 Jun;
12(1):9782.
PMID: 35697724
Previous studies reported conflicting results regarding an association between serum albumin concentration and the cumulative incidence of remission of proteinuria in adult patients with minimal change disease (MCD). The present...
13.
Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients
Hori M, Yasuda K, Takahashi H, Kondo C, Shirasawa Y, Ishimaru Y, et al.
Sci Rep
. 2022 May;
12(1):7781.
PMID: 35546172
Denosumab is reported to increase bone mineral density (BMD) among haemodialysis patients; however, hypocalcaemia is a serious adverse effect among chronic kidney disease (CKD) patients. Identifying which patients will show...
14.
Okada E, Morisada N, Horinouchi T, Fujii H, Tsuji T, Miura M, et al.
Kidney Int Rep
. 2022 May;
7(4):857-866.
PMID: 35497811
Introduction: Autosomal dominant tubulointerstitial kidney disease (ADTKD)- is predominantly caused by frameshift mutations owing to a single-base insertion into the variable number tandem repeat (VNTR) region in . Because of...
15.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, et al.
J Nephrol
. 2022 Apr;
35(4):1135-1144.
PMID: 35366214
Background: Minimal change disease (MCD) is characterized by a nephrotic syndrome usually steroid-sensitive and a high incidence of relapse of proteinuria. Previous cohort studies have reported conflicting results regarding the...
16.
Hori M, Yasuda K, Takahashi H, Matsuoka Y, Tsujita M, Nishihira M, et al.
Clin Exp Nephrol
. 2022 Mar;
26(7):724-732.
PMID: 35304690
Background: Although the prevalence of osteoporosis and fractures in the first 6-12 months post-renal transplantation is high, little is known about the utility of bone mineral density (BMD) to predict...
17.
Nakayama T, Yamamoto J, Ozeki T, Yasuda K, Yamazaki C, Ito T, et al.
J Med Ultrason (2001)
. 2022 Mar;
49(2):241-252.
PMID: 35298744
Purpose: Left ventricular hypertrophy (LVH) is a well-known risk factor for poor clinical outcomes in patients undergoing dialysis. However, little evidence supports the above notion in Japan, and the influence...
18.
Hattori K, Shimizu R, Tanaka S, Terashima T, Hiramatsu M, Shimomura T, et al.
CEN Case Rep
. 2022 Feb;
11(4):412-416.
PMID: 35199316
Fibrillary glomerulonephritis (FGN) is a rare glomerular disease. FGN is characterized by the deposition of randomly arranged, nonbranching microfibrils in the mesangium and glomerular basement membrane. The discovery of DNAJ...
19.
Hori M, Yasuda K, Takahashi H, Yamazaki C, Morozumi K, Maruyama S
PLoS One
. 2021 May;
16(5):e0251912.
PMID: 34014999
Introduction: Bone mineral density (BMD) measured with dual-energy X-ray absorptiometry (DXA) can be used to predict fractures, but its clinical utility has not been fully established in chronic kidney disease...
20.
Tsujita M, Goto N, Futamura K, Okada M, Hiramitsu T, Narumi S, et al.
Clin Exp Nephrol
. 2021 Jan;
25(5):537-544.
PMID: 33411116
Background: In living kidney transplantation, predicting the risk of end-stage kidney disease in the organ donors though crucial remains to be resolved. Thus, any useful biomarker to predict kidney outcome...